What is Schrodinger?
Founded in 1990, Schrodinger provides sophisticated software solutions essential for life sciences and materials research. Its core technology empowers scientific innovation by enabling advanced molecular simulations, crucial for fields such as drug discovery and materials science. The company strategically partners with leading entities across the biotechnology, pharmaceutical, chemical, and electronics sectors. With a global operational footprint spanning the United States, Europe, Japan, and India, and extending through business partnerships in China and Korea, Schrodinger is positioned as a key enabler of scientific advancement worldwide.
How much funding has Schrodinger raised?
Schrodinger has raised a total of $151M across 5 funding rounds:
Other Financing Round
$10M
Other Financing Round
$20M
Other Financing Round
$22M
Unspecified
$85M
Series A
$14M
Other Financing Round (2010): $10M with participation from Cascade Investment
Other Financing Round (2012): $20M led by Bill Gates
Other Financing Round (2015): $22M supported by Scott Becker
Unspecified (2019): $85M featuring Qiming Venture Partners, Bill & Melinda Gates Foundation, WuXi AppTec's Corporate Venture Fund, Deerfield, GV, and Baron
Series A (2020): $14M backed by Grey Wolf Therapeutics, Canaan, and Andera Partners
Key Investors in Schrodinger
Cascade Investment
Cascade Investment Group is a financial services firm with over 100 years of combined investment experience, dedicated to enhancing clients' financial well-being. They offer a range of personalized services including wealth management, investment advice, financial planning, and retirement planning, tailored to meet individual client needs.
Qiming Venture Partners
Qiming Venture Partners is a leading investment firm that focuses on early-stage and growth-stage technology and healthcare companies. They are known for their deep industry expertise and extensive network, supporting innovative startups in China and globally.
Bill & Melinda Gates Foundation
Established in 2000 and headquartered in Seattle, Washington, The Bill & Melinda Gates Foundation is an organization that focuses on supporting individuals experiencing hunger and extreme poverty in leading healthier lives.
What's next for Schrodinger?
The recent major strategic investment signals Schrodinger's transition into a scaling phase, likely focusing on expanding its market reach, enhancing its software capabilities, and forging new research collaborations. This infusion of capital is expected to fuel further development of its unique platform, which combines physics-based modeling with machine learning to accelerate innovation in pharmaceutical and materials design. Schrodinger's ongoing commitment to establishing strategic partnerships across various industries suggests a future trajectory aimed at solidifying its role as a critical technology provider for scientific breakthroughs.
See full Schrodinger company page
